Reena V. Kartha

1.8k total citations
49 papers, 1.3k citations indexed

About

Reena V. Kartha is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, Reena V. Kartha has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 17 papers in Physiology and 7 papers in Cell Biology. Recurrent topics in Reena V. Kartha's work include Lysosomal Storage Disorders Research (14 papers), MicroRNA in disease regulation (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Reena V. Kartha is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), MicroRNA in disease regulation (6 papers) and Peroxisome Proliferator-Activated Receptors (6 papers). Reena V. Kartha collaborates with scholars based in United States, Egypt and India. Reena V. Kartha's co-authors include Subbaya Subramanian, Márcia R. Terluk, James C. Cloyd, Usha Mishra, Paul Tuite, Uma Sundram, Lisa D. Coles, Arul Vadivel, Jayakumar Rajadas and Jie Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Reena V. Kartha

45 papers receiving 1.3k citations

Peers

Countries citing papers authored by Reena V. Kartha

Since Specialization

Citations

This map shows the geographic impact of Reena V. Kartha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reena V. Kartha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reena V. Kartha more than expected).

Fields of papers citing papers by Reena V. Kartha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reena V. Kartha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reena V. Kartha. The network helps show where Reena V. Kartha may publish in the future.

Co-authorship network of co-authors of Reena V. Kartha

This figure shows the co-authorship network connecting the top 25 collaborators of Reena V. Kartha. A scholar is included among the top collaborators of Reena V. Kartha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reena V. Kartha. Reena V. Kartha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Model-informed repurposing of eliglustat for treatment and prophylaxis of Shiga toxin-producing Escherichia coli hemolytic-uremic syndrome (STEC-HUS) in children 2025 ·Pediatric Nephrology ·(unknown), Jolien J. M. Freriksen, (unknown), Reena V. Kartha, Saskia N. de Wildt, Kioa L. Wijnsma, Nicole C. A. J. van de Kar, Rob ter Heine	0
2	Emerging biomarkers in Gaucher disease 2025 ·Advances in clinical chemistry ·(unknown), Márcia R. Terluk, (unknown), Neal J. Weinreb, Reena V. Kartha	2
3	Examination of oxidative stress and glutamate as potential mechanisms of N-acetylcysteine in the treatment of non-suicidal self-injury in young people assigned female at birth: randomised trial 2025 ·BJPsych Open ·(unknown), Bonnie Klimes‐Dougan, (unknown), Bryon A. Mueller, Young Woo Park, Gülin Öz, Lynn E. Eberly, (unknown), Reena V. Kartha, James C. Cloyd, Lisa D. Coles, Kathryn R. Cullen	0
4	Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers 2024 ·Clinical Pharmacology & Therapeutics ·(unknown), Rajesh Krishna, (unknown), (unknown), Amitava Mitra, (unknown), Yuen Yi Hon, Bilal Abuasal, Rana B. Bakhaidar, Youssef M. Roman, (unknown), James C. Cloyd, Munjal Patel, Reena V. Kartha, Islam R. Younis	6
5	Economics, externalities and rare disease 2024 ·SHILAP Revista de lepidopterología ·C. Ford Runge, (unknown), (unknown), (unknown), Reena V. Kartha	2
6	N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant 2023 ·Antioxidants ·(unknown), Márcia R. Terluk, Reena V. Kartha	47
7	Gaucher disease – more than just a rare lipid storage disease 2022 ·Journal of Molecular Medicine ·(unknown), Subbaya Subramanian, Neal J. Weinreb, Reena V. Kartha	29
8	Patients with Gaucher disease display systemic oxidative stress dependent on therapy status 2020 ·Molecular Genetics and Metabolism Reports ·Reena V. Kartha, Márcia R. Terluk, Roland Brown, (unknown), Usha Mishra, Kyle Rudser, Heather Lau, (unknown), James C. Cloyd, Neal J. Weinreb	20
9	Gaucher disease and SARS-CoV-2 infection: Emerging management challenges 2020 ·Molecular Genetics and Metabolism ·Pramod K. Mistry, Manisha Balwani, Deborah Barbouth, T. Burrow, Edward I. Ginns, Özlem Göker-Alpan, Gregory A. Grabowski, Reena V. Kartha, Priya S. Kishnani, Heather Lau, (unknown), Grisel Lopez, Gustavo Maegawa, Seymour Packman, Carlos E. Prada, Barry E. Rosenbloom, (unknown), (unknown), Neal J. Weinreb, Ellen Sidransky	23
10	GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies 2019 ·Molecular Genetics and Metabolism ·(unknown), Neal J. Weinreb, James C. Cloyd, Paul Tuite, Reena V. Kartha	19
11	Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson’s disease: a pilot randomized controlled trial 2018 ·Pilot and Feasibility Studies ·Corjena Cheung, Rozina Bhimani, Jean F. Wyman, Jürgen Konczak, Lei Zhang, Usha Mishra, Márcia R. Terluk, Reena V. Kartha, Paul Tuite	57
12	Intravenous Administration of Stable-Labeled N-Acetylcysteine Demonstrates an Indirect Mechanism for Boosting Glutathione and Improving Redox Status 2015 ·Journal of Pharmaceutical Sciences ·Jie Zhou, Lisa D. Coles, Reena V. Kartha, Nardina Nash, Usha Mishra, Troy C. Lund, James C. Cloyd	38
13	Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy 2015 ·CNS Drugs ·Reena V. Kartha, Jie Zhou, (unknown), H. Schröder, Paul J. Orchard, James C. Cloyd	10
14	Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation 2014 ·Frontiers in Genetics ·Reena V. Kartha, Subbaya Subramanian	321
15	MicroRNAs as Biomarkers in Cancer 2013 ·SHILAP Revista de lepidopterología ·(unknown), Reena V. Kartha, Subbaya Subramanian	32
16	MicroRNA-mediated gene regulations in human sarcomas 2012 ·Cellular and Molecular Life Sciences ·Subbaya Subramanian, Reena V. Kartha	16
17	Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma 2011 ·Bone ·Venugopal Thayanithy, Aaron L. Sarver, Reena V. Kartha, Lihua Li, Andrea Y. Angstadt, Matthew Breen, Clifford J. Steer, Jaime F. Modiano, Subbaya Subramanian	109
18	MicroRNAs in Cardiovascular Diseases: Biology and Potential Clinical Applications 2010 ·Journal of Cardiovascular Translational Research ·Reena V. Kartha, Subbaya Subramanian	35
19	A Malignant Cutaneous Neuroendocrine Tumor With Features of Merkel Cell Carcinoma and Differentiating Neuroblastoma 2009 ·American Journal of Dermatopathology ·(unknown), (unknown), Reena V. Kartha, Alison Uzieblo, Mahendra Ranchod, Uma Sundram	9
20	Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis 2007 ·Modern Pathology ·Reena V. Kartha, Uma Sundram	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact